STOCK TITAN
  1. Home
  2. News
  3. MOVE

Movano Inc. - $MOVE STOCK NEWS

Welcome to our dedicated page for Movano news (Ticker: $MOVE), a resource for investors and traders seeking the latest updates and insights on Movano stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Movano's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Movano's position in the market.

News
Movano Health Announces Proposed Public Offering
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) Announces Proposed Public Offering of Common Stock. Movano Health, a healthcare solutions company, is proposing to sell shares of its common stock in an underwritten public offering. The company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of shares of common stock sold in the offering. The net proceeds from the offering will be used for general corporate purposes, including funding product development and commercialization activities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.09%
Tags
offering
-
News
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
Rhea-AI Summary
Movano Health, a healthcare solutions company, will report Q3 2023 financial results on November 14. A conference call and webcast will be held at 2:00 p.m. PST.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
News
Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring
Rhea-AI Summary
Movano Health announces the results of its blood pressure clinical study, demonstrating the accuracy of its cuffless, radio frequency-enabled blood pressure device. The prototype achieved an overall mean absolute difference of 5.9 mmHg, below the standard requirement of 7 mmHg. Movano Health's 4 x 6.7 mm System-on-a-Chip (SoC) has improved the accuracy of its blood pressure measurements. The wearable prototype represents a small and accessible way to measure blood pressure.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.57%
Tags
none
News
Movano Health to Launch the Evie Ring on November 20
Rhea-AI Summary
Movano Health announced its launch plans for the Evie Ring, a smart ring designed for women's health. Starting on November 20, customers can order the ring for $269 through the website www.eviering.com. The ring measures health and wellness metrics, provides personalized insights, and accommodates swelling without compromising style. Movano Health has made progress in product testing, manufacturing scalability, and FDA regulatory process. The company is also conducting testing with a major health insurer and preparing to showcase the ring at CES 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.51%
Tags
none
-
News
Evie Ring Welcomes Cardiologist and Stanford University Associate Professor Dr. Fátima Rodriguez to its Medical Advisory Board
Rhea-AI Summary
Dr. Fátima Rodriguez joins Movano Health's Medical Advisory Board
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News
Movano Health, Maker of the Evie Ring, Selects Jay Group as its Fulfillment Provider in Preparation for its Commercial Launch
Rhea-AI Summary
Movano Health has selected Jay Group as its 3PL for the shipping of its medical-grade health wearable, the Evie Ring. The partnership will leverage Jay Group's fulfillment analytics and operations to support the November launch of the product. Movano Health plans to store inventory of the Evie Ring in Jay Group's FDA registered fulfillment centers across the US.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.74%
Tags
none
News
Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) reported financial results for the three months ending June 30, 2023. The company made significant progress with the development of the Evie Ring, submitted its first 510(k) application to the FDA, and generated strong consumer interest through strategic marketing efforts. Movano plans to launch Evie before Black Friday 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.02%
Tags
earnings
-
News
Evie Ring Establishes Medical Advisory Board Furthering its Commitment to Bringing a Medical-Grade Wearable to Women
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) announces the formation of a Medical Advisory Board composed of healthcare industry experts in women's health, mental health, and sleep. The board will provide trusted advice to the Evie team for the development of its medical-grade smart ring for women. The board members include Dr. Mary Claire Haver, Dr. Ruth C. White, and Dr. Andrea Matsumura, who are highly regarded specialists in their respective fields.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
management
-
News
Movano Inc. to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
conferences earnings
News
Movano Health Achieves Major Milestone with First FDA Filing for Evie Ring's Pulse Oximeter
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Stock MOVE logo
Movano Inc.

Nasdaq:MOVE

MOVE Rankings

#4848 Ranked by Market Cap
#5022 Ranked by Stock Gains
N/A Ranked by Dividends

MOVE Stock Data

42.75M
25.98M
15.3%
12.87%
0.19%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
PLEASANTON

About MOVE

movano is a health-focused technology company that believes glucose is an important health metric to continuously track, as glucose levels serve as a proxy for metabolic health and risk for chronic disease, such as diabetes. we also believe that whether you are a person with diabetes, prediabetes or someone looking to pursue a healthier lifestyle, monitoring and managing your glucose levels shouldn’t be painful, complicated or conspicuous.